Home Nucleus Pharmaceuticals Mexico CAR-T Cell Therapy Treatment Market to 2032

Mexico CAR-T Cell Therapy Treatment Market to 2032

Overview

The Mexico CAR-T Cell Therapy Treatment Market is expected to reach a 25.77 USD Million by 2032 and is projected to grow at a CAGR of 24.57% from 2025 to 2032.

Revenue, 2024 (USD Million)
9.16
Forecast, 2032 (USD Million)
25.77
CAGR, 2024 - 2032
24.57%
Report Coverage
Mexico

Mexico CAR-T Cell Therapy Treatment Market 2018-2032 USD Million

Mexico CAR-T Cell Therapy Treatment Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 9.16 USD Million
  • Projected Market Size (2032): 25.77 USD Million
  • CAGR (2025-2032): 24.57%

Key Findings of Mexico CAR-T Cell Therapy Treatment Market

  • The Mexico CAR-T Cell Therapy Treatment Market was valued at 9.16 USD Million in 2024.
  • The Mexico CAR-T Cell Therapy Treatment Market is likely to grow at a CAGR of 24.57% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Antigens On Hematologic Malignancies in Targeted Antigens Segment accounted for the largest share of the market with a revenue of 9.16 USD Million
  • The fastest growing segment Diffuse Large B-Cell Lymphoma in Therapeutic Application Segment grew Fastest with a CAGR of 31.24% during the forecast period from 2024 to 2032.

Mexico CAR-T Cell Therapy Treatment Market Scope

Mexico CAR-T Cell Therapy Treatment Market Segmentation & Scope
Distribution Channel
  • Others
  • Hospital Pharmacy
End User
  • Others
  • Hospitals
  • Specialty Clinics
Therapeutic Application
  • Acute Lymphoblastic Leukaemia (ALL)
  • Mantle Cell Lymphoma
  • Multiple Myeloma
  • Hematologic Malignancies
  • Lung Cancer
  • Chronic Lymphocytic Leukemia
  • Gastric Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Others
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
Brand
  • Others
  • Yescarta
  • Kymriah
  • Tecartus
Targeted Antigens
  • Antigens On Solid Tumors
  • Others
  • Antigens On Hematologic Malignancies
Product
  • Autologous CAR-T Cells
  • Allogeneic CAR-T Cells
Structure
  • First Generation CAR-T Cells
  • Second Generation CAR-T Cells
  • Third Generation CAR-T Cells
  • Fourth Generation CAR-T Cells

Mexico CAR-T Cell Therapy Treatment Market Data Coverage Insights

Study Period 2024-2032
Base Year 2019
Unit Revenue in USD Million
Market Value in 2024 9.16 USD Million
Market Value in 2032 25.77 USD Million
CAGR (2025-2032) 24.57%
Historic Data 2016-2023
Market Segments Covered Distribution Channel, End User, Therapeutic Application, Brand, Targeted Antigens, Product, Structure

Regional Insights:

  • Leading Market (2024-2032): Mexico, leading in terms of revenue 9.16 USD Million in 2024
    • Key Country: Mexico, leading in terms of revenue with value of 9.16 USD Million in 2024.

Segments and Scope

  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Distribution Channel
    • Hospital Pharmacy is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 6.68 USD Million in the year 2024.
    • Hospital Pharmacy is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 24.24 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By End User
    • Hospitals is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 6.68 USD Million in the year 2024.
    • Specialty Clinics is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 24.24 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Therapeutic Application
    • Follicular Lymphoma is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 6.74 USD Million in the year 2024.
    • Diffuse Large B-Cell Lymphoma is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 22.33 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Brand
    • Yescarta is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 6.74 USD Million in the year 2024.
    • Kymriah is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 22.33 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Targeted Antigens
    • Antigens On Hematologic Malignancies is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 9.16 USD Million in the year 2024.
    • Antigens On Hematologic Malignancies is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 24.57 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Product
    • Autologous CAR-T Cells is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 9.16 USD Million in the year 2024.
    • Autologous CAR-T Cells is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 24.57 % in forecast period 2025-2032.
  • Mexico CAR-T Cell Therapy Treatment Market to 2032, By Structure
    • Second Generation CAR-T Cells is the largest segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 9.16 USD Million in the year 2024.
    • Second Generation CAR-T Cells is the Fastest growing segment in Mexico CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 24.57 % in forecast period 2025-2032.

Mexico CAR-T Cell Therapy Treatment Market Company Share Analysis

 
Company Name Company Share Analysis
Novartis AG
Kite Pharma Inc.
Mexico CAR-T Cell Therapy Treatment Market Company Share Analysis

Mexico CAR-T Cell Therapy Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

Mexico CAR-T Cell Therapy Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

Mexico CAR-T Cell Therapy Treatment Market Company Profiling

Mexico CAR-T Cell Therapy Treatment Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Mexico CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Distribution Channel, End User, Therapeutic Application, Brand, Targeted Antigens, Product, Structure.
Mexico CAR-T Cell Therapy Treatment Market was valued at USD 9.16(Revenue in USD Million) in 2019.
Mexico CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 24.57% during the forecast period of 2024 to 2032.
The Antigens On Hematologic Malignancies segment is expected to dominate the Mexico CAR-T Cell Therapy Treatment Market, holding a largest market share of 9.16 USD Million in 2024

Mexico CAR-T Cell Therapy Treatment Market Scope

Mexico CAR-T Cell Therapy Treatment Market Segmentation & Scope
Distribution Channel
  • Others
  • Hospital Pharmacy
End User
  • Others
  • Hospitals
  • Specialty Clinics
Therapeutic Application
  • Acute Lymphoblastic Leukaemia (ALL)
  • Mantle Cell Lymphoma
  • Multiple Myeloma
  • Hematologic Malignancies
  • Lung Cancer
  • Chronic Lymphocytic Leukemia
  • Gastric Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Others
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
Brand
  • Others
  • Yescarta
  • Kymriah
  • Tecartus
Targeted Antigens
  • Antigens On Solid Tumors
  • Others
  • Antigens On Hematologic Malignancies
Product
  • Autologous CAR-T Cells
  • Allogeneic CAR-T Cells
Structure
  • First Generation CAR-T Cells
  • Second Generation CAR-T Cells
  • Third Generation CAR-T Cells
  • Fourth Generation CAR-T Cells
Frequently Asked Questions
The Mexico CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Distribution Channel, End User, Therapeutic Application, Brand, Targeted Antigens, Product, Structure.
Mexico CAR-T Cell Therapy Treatment Market was valued at USD 9.16(Revenue in USD Million) in 2019.
Mexico CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 24.57% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico CAR-T Cell Therapy Treatment Market for final year is USD 25.77 (USD Million).

Mexico CAR-T Cell Therapy Treatment Market Company Profiling

Mexico CAR-T Cell Therapy Treatment Market Company Profiling
Frequently Asked Questions
The Mexico CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Distribution Channel, End User, Therapeutic Application, Brand, Targeted Antigens, Product, Structure.
Mexico CAR-T Cell Therapy Treatment Market was valued at USD 9.16(Revenue in USD Million) in 2019.
Mexico CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 24.57% during the forecast period of 2024 to 2032.
The estimated market value of the Mexico CAR-T Cell Therapy Treatment Market for final year is USD 25.77 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES